Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenghong Holding Group is a leading Chinese conglomerate and a Fortune Global 500 company, primarily active in the petrochemical, textile, and energy industries. In the life sciences and healthcare sectors, the group operates through its New Materials and Industrial Biotech divisions, focusing on the production of medical-grade polymers, high-performance fibers for protective equipment, and bio-based chemicals such as 1,3-propanediol (PDO). Additionally, the group maintains a presence in healthcare services through its Shenghong Health division, which invests in and operates medical facilities and health management programs in China. While not a therapeutic drug developer, Shenghong is a significant player in the healthcare supply chain and medical infrastructure. The company is headquartered in Suzhou and maintains a significant global manufacturing and R&D footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenghong Group Holdings.